The promyelocytic leukemia protein (PML) is the main structural component of the nuclear matrix structures termed nuclear domain 10 (ND10) or PML nuclear bodies (PML-NBs). PML and ND10 structures have been shown to mediate an intrinsic immune response against a variety of different viruses. Their role during retroviral replication, however, is still controversially discussed. In this study, we analyzed the role of PML and the ND10 components Daxx and Sp100 during retroviral replication in different cell types. Using cell lines exhibiting a shRNA-mediated knockdown, we found that PML, but not Daxx or Sp100, inhibits HIV and other retroviruses in a cell type-dependent manner. The PML-mediated block to retroviral infection was active in primary human fibroblasts and murine embryonic fibroblasts but absent from T cells and myeloid cell lines. Quantitative PCR analysis of HIV cDNA in infected cells revealed that PML restricts infection at the level of reverse transcription. Our findings shed light on the controversial role of PML during retroviral infection and show that PML contributes to the intrinsic restriction of retroviral infections in a cell type-dependent manner.
Introduction
The promyelocytic leukemia protein (PML/TRIM19) is a member of the tripartite motif (TRIM) protein family and contains an amino-terminal TRIM motif consisting of a RING domain, two B-Boxes and a coiled coil domain [1, 2] . Seven different PML isoforms have been described, all of which contain a TRIM motif but differ within their carboxyterminal sequences due to differential splicing. The PML isoforms I through VI are located in the nucleus of the cell, whereas isoform VII is exclusively found in the cytoplasm of the cells. Within the nucleus, PML is the major organizing component of nuclear domain 10 (ND10) structures. Within ND10, PML is modified by binding to the small ubiquitin-like modifier (SUMO), which leads to the stabilization of the ND10 structures and the recruitment of the permanently ND10-associated proteins Daxx and Sp100, as well as many other transiently associated proteins depending on exogenous influences and cellular conditions [3, 4] . PML and ND10 structures have been implicated in a variety of different functions, RPMI 1640 medium containing 10% FBS. HFF cells stably overexpressing the PML isoforms I to VI from a retroviral vector and THP-1 cells stably expressing shRNAs directed against PML, Sp100, and Daxx were described in previous studies [23] . All cells transduced with lentiviral shRNA vectors were kept in medium containing additional 5 µg/mL puromycin.
Plasmids
Lentiviral vectors encoding short hairpin RNA targeting PML (pLVX-shPML), Daxx (pLVX-shDaxx), or SP100 (pLVX-shSP100) or scrambled shRNA (pLVX-shC) have been described in previous studies [23] . The env-deficient HIV-1 reporter plasmid pNL43-E´-GFP encodes the EGFP reporter gene in place of the nef open reading frame and has been described in previous studies [24] . The reporter plasmid pNL43-E´-CMVGFP expresses GFP under control of an additional CMV promoter within nef [24] . The HIV-1 reporter construct pNL4-3eGFP containing a Matrix-eGFP fusion protein has been described in previous studies and was donated by B. Schmidt [25] . The lentiviral transfer vector pWPI was donated by Didier Trono (Addgene plasmid # 12254) and expresses the EGFP reporter gene under the control of the cellular promoter EF1α. The env-deficient retroviral reporter constructs pNL-luc3-E´(HIV-luc) [26] , pSIVmac239-luc-E´(SIV-luc) [24] , pSARM-EGFP (MPMV-GFP) [27] , and pMXSfi-EGFP (MLV-GFP) [24] have been described in previous studies. The lentiviral packaging vector p∆R8.91 expresses HIV gagpol and has also been described in previous studies [28] .
Virus Preparation
ShRNA-containing particles were produced by cotransfection of 293T cells with the respective pLVX-shRNA vector, the lentiviral packaging plasmid p∆R8.91, and the pVSV-G vesicular stomatitis virus glycoprotein expression plasmid at a mass ratio of 2:2:1 using calcium phosphate coprecipitation. Reporter viruses were produced in 293T cells cotransfected with env-deficient reporter virus plasmids and pVSV-G. HIV-GFP and HIV-CMVGFP were generated by cotransfecting pNL43-E´-GFP or pNL43-E´-CMVGFP together with pVSV-G at a mass ration of 4:1. Fluorescently labeled HIV-MAGFP particles were produced by cotransfecting pNL-43eGFP and VSV-G at a mass ratio of 4:1. HIV-GFP ∆acc was generated by cotransfection of pWPI, p∆R8.91 and pVSV-G at a mass ration of 2:2:1. HIV-1-Luciferase (HIV-luc) reporter virus was generated by cotransfection of pNL.Luc3-E´and pVSV-G at a mass ratio of 5:1. MLV-GFP reporter virus was produced by transfection with pMX-GFP, the packaging plasmid pHIT-60, and pVSV-G at a mass ratio of 4:2:1. MPMV-GFP reporter virus was generated by transfection of pSARM-EGFP and pVSV-G at a mass ratio of 4:1. After 6 h, the culture medium of the transfected cells was replaced. Supernatants were harvested 48 h posttransfection, passed through 0.4-µm-pore size filters, aliquotted and frozen at´80˝C.
SIV and HIV luciferase reporter viruses were normalized upon infection of 293T cells by luciferase assay according to the manufacturer's instructions (Promega, Fitchburg, WI, USA). Therefore, 1ˆ10 4 293T cells were infected with 10, 30, and 50 µL of luciferase reporter virus. After 72 h, infected cells were lysed, and luciferase activity was quantified as counts per second (cps). Similarly, GFP reporter viruses were titered on 293T cells and analyzed 72 h postinfection via flow cytometry. Lentiviral shRNA vectors were normalized on p24 capsid protein content determined in ELISA assays, which were conducted by the diagnostic section of the institute.
Reporter Virus Infection Assays
For HFF and MEF infections, 1ˆ10 5 cells were seeded into 6-well plates and transduced with GFP reporter viruses the next day at a MOI of 0.3 if not indicated otherwise. To assess the role of sodium arsenite during HIV infection, HFF cells were treated with the indicated amounts (1 to 4 µM) of NaAsO 2 (Sigma, St. Louis, MO, USA) for 12 h prior to infection and 24 h postinfection. For luciferase reporter virus infections, 2ˆ10 4 HFF or MEF cells were infected with increasing amounts of luciferase reporter virus (cps) unless otherwise indicated. Human T cell lines and myeloid cells were infected with GFP reporter viruses at the indicated MOI or with increasing amounts of luciferase reporter virus. After six hours, medium of the transduced cells was replaced. The number of infected cells was determined after 72 h by flow cytometry, and luciferase activity in infected cells (counts per second, cps) was quantified via luciferase assay 72 h postinfection.
Quantitative Real-Time PCR (qPCR)
HFFs or MEFs were infected at a MOI of 1, with virus stocks treated for 1 h with 50 U of Benzonase/mL (Sigma) to remove contaminating plasmid DNA. At 14 h prior to infection, 25 µM reverse transcriptase inhibitor (AZT) was added to one well to control for residual plasmid DNA contamination. At 12 h, 24 h, and 48 h postinfection, total cellular DNA was isolated using a QIAamp Blood DNA Kit (Qiagen, Chatsworth, CA, USA). Reverse transcripts in 125 ng (HFF) or 250 ng (MEF) of total DNA were quantitated by qPCR with an ABI Prism 7300 (Applied Biosystems). The primer pairs used to detect HIV late reverse transcription products were MH531 (5'-TGTGTGCCCGTCTG TTGTGT), MH532 (5'-GAGTCCTGCGTCGAGAGA) and the TaqMan probe LRT-P 5'-(FAM)-CAGT GGCGCCCGAACAGGGA-(TAMRA)-3'. To detect HIV 2LTR circles, MH535 (5'-AACTAGGGAA CCCACTGCTTAAG) and MH536 (5'-TCCACAGATCAAGGATATCTTGTC) together with the TaqMan probe MH603 (5'-(FAM)-ACACTACTTGAAGCACTCAAGGCAAGC TTT-(TAMRA)-3') were used. Standard curves were generated using serially diluted proviral and 2-LTR plasmids.
Vpr-BLaM Entry Assay
β-Lactamase-containing virions were produced by cotransfection of 293T cells with the proviral plasmid pNL4-3luc E´, pMM310, a vector that encodes a β-lactamase-Vpr fusion protein, and pVSV-G at a mass ration of 2:2:1. Virus stocks were normalized on equal infectivity and used to transduce HFF shC or shPML cells at a MOI of 1. After 5 h, the cells were washed with PBS and incubated with 2 mM of the BLaM substrate CCF2 (Gene Blazer Kit, Aurora Biosciences, San Diego, CA, USA), 1% probenecid in 1.0 mL serum-free DMEM containing 10 mM Hepes at 25˝C. After 18 h, cells were washed, fixed in 1% paraformaldehyde for 10 min, and analyzed by flow cytometry. Cells containing cleaved substrate were detected with a 424/44-nm band pass filter (blue) and uncleaved substrate was detected with a 516/20-nm band pass filter (green) by flow cytometry.
Immunoblot Analysis
All cells were lysed in NP40 lysis buffer (10 mM TrisHCl (pH 7.5), 150 mM NaCl, 2 mM EDTA, 0.5% NP-40, Halt Protease Inhibitor). Lysates were quantified by Bradford assay (Carl Roth, Karlsruhe, Germany) and 30 µg per sample were separated by SDS-PAGE, transferred to PDVF membranes and probed with different primary antibodies. To detect PML in immunoblots, the rabbit polyclonal antibodies A301-167A and A301-168A (Bethyl-Laboratories, Montgomery, TX, USA) were used in combination. To detect human Daxx, the rabbit monoclonal antibody E94 (BioCat, Heidelberg, Germany) was used, and, to detect SP100, the rabbit polyclonal AB11377-1-AP (Acris, San Diego, CA, USA) was used. As loading control, membranes were probed with murine antibodies directed against the house keeping genes GAPDH, HSP90, or β-Actin. The membranes were then probed with anti-mouse or anti-rabbit horseradish peroxidase (HRP)-labeled secondary antibody (goat, GE Healthcare) and visualized using HRP substrate (Pierce, Rockford, IL, USA).
Immunofluorescence Analysis
For indirect immunofluorescence analysis, adherent cells were grown on poly-lysine-coated coverslips in 24-well dishes (2.5ˆ10 4 cells/well). After 24 h, cells were fixed with 4% paraformaldehyde for 20 min at room temperature. For the analysis of PML localization upon HIV infection, 3.0ˆ10 5 HFF cells were grown on coverslips for 24 h in 6 well dishes, infected with HIV-MAGFP at a MOI of 3, and harvested at the indicated time points. Non-adherent cells were seeded at 1ˆ10 5 cells/50 µL in single wells of well-containing cover slips, dried, and fixed in 50 µL 4% paraformaldehyde (Applichem, Darmstadt, Germany) for 60 min. Subsequently, all cells were washed with PBS three times followed by permeabilization using a 0.4% saponine (Applichem) solution on ice for 20 min. After another washing step, cells were stained with primary antibodies against PML, SP100, or Daxx overnight at 4˝C. The corresponding secondary antibody dilutions were used to incubate the cells for 60 min at room temperature. Finally, cells were stained with DAPI nucleic acid stain (4 1 ,6-diamidino-2-phenylindole, Invitrogen, Carlsbad, CA, USA) and mounted using Fluoromount mounting medium (Sigma). Samples were analyzed using the Leica TCS SP5 confocal laser-scanning microscope (Leica, Wetzlar, Germany), and the resulting images were processed using Photoshop software (Adobe, San José, CA, USA).
Results
PML knockdown correlates with enhanced retroviral infectivity in primary human fibroblasts. To clarify the role of PML/TRIM19 during retroviral replication, we infected primary human foreskin fibroblasts (HFF) with retroviral reporter viruses. We used HFF cells since they are a well-characterized model system to analyze the antiviral effect of PML on the replication of different viruses, e.g., herpesviruses [29] . To analyze the effect of PML on retroviral replication, we generated knockdown cell lines by transducing HFF cells with a lentiviral vector expressing shRNA targeting PML (shPML) or control shRNA (shC). We found that the knockdown of PML efficiently reduced the amount of total PML protein in shPML cells when analyzed by immunoblotting ( Figure 1A ). The various bands visible in the lysate of control cells indicate the different PML isoforms as well as differentially modified proteins. We found that the expression of shRNA against PML efficiently down-regulates most PML variants ( Figure 1A ). In HFF shC cells, we found PML to be localized in nuclear speckles, the previously described ND10 structures ( Figure 1B) . To analyze the effect of the PML knockdown on HIV infectivity, we transduced shC-or shPML-expressing HFFs with increasing amounts of VSV-G pseudotyped HIV-GFP reporter virus and quantified the number of GFP expressing cells three days postinfection by flow cytometry ( Figure 1C ). We found a three-to four-fold enhancement of HIV infectivity in HFFs lacking PML compared to shC cells. This suggests that the expression of PML restricts HIV infection during the early phases of the viral life cycle in primary human fibroblasts. The inhibitory effect of PML on HIV infectivity did not change over a wide range of multiplicity of infections (MOIs), suggesting that the antiviral effect of PML is not saturable by high viral loads ( Figure 1C ). Many lentiviral accessory proteins play an important role in overcoming intrinsic antiviral restrictions. Vpu, for example, is counteracting the Tetherin-mediated block, Vif is blocking the APOBEC3-mediated restrictions, and Vpx/Vpr disarms the SAMHD1-mediated inhibition of retroviral infection. We therefore wondered whether the accessory proteins Vpu, Vif, or Vpr of HIV-1 would interfere with the PML-mediated reduction of infectivity ( Figure 1D ). Thus, we compared the infectivity of HIV-GFP reporter viruses encoding all accessory proteins but nef (HIV-GFP) or lacking all accessory proteins (HIV-GFP ∆acc) on HFF shC and shPML cells. Three days postinfection, we found that both viruses infect HFF cells almost to the same levels. Compared to shPML cells, we found that the infectivity of HIV-GFP was strongly reduced in shC cells independently of HIV accessory proteins. It is therefore unlikely that HIV-1 encodes an accessory protein that counteracts the PML-mediated restriction ( Figure 1D ). Turelli et al. have shown that the degradation of ND10 structures upon arsenic treatment enhanced HIV-1 infectivity [18] . To determine whether treatment with arsenical compounds mimics the shRNA-mediated knockdown of PML in HFF cells, we treated shPML and shC HFF with increasing amounts of sodium arsenite (NaAsO 2 ), which has been shown to down-regulate PML protein level even more efficiently than As 2 O 3 [30] . Sodium arsenite was added 12 h prior to infection with the HIV-GFP reporter virus at a MOI of 0.3 ( Figure 1E ). After additional 24 h, the NaAsO 2 -containing medium was replaced to minimize cytotoxic effects, and viral infectivity was determined 72 h postinfection by flow cytometry. We were able to confirm the findings of Turelli et al. and found that arsenical compound treatment increases HIV infectivity on shC cells. On shC cells, incubation with 4 µM arsenite enhanced viral infection by 2.4-fold and up to the level of viral infectivity on shPML-expressing HFFs, suggesting that the shRNA-mediated knockdown of PML can indeed be mimicked by sodium arsenite treatment. However, we also observed a slight enhancement of HIV infection upon treatment of shPML cells (up to 1.5-fold). The enhancement in shPML cells might be due to the inactivation of residual PML molecules and ND10 structures or by pleiotropic effects of arsenical compounds in the target cells, making the shRNA-mediated knockdown of PML the preferred tool to analyze the role of PML during retroviral replication. Since we found that the knockdown of PML enhanced HIV-GFP infection in HFFs, we next asked whether the overexpression of PML would be able to reduce infectivity in these cells. We therefore employed previously described HFF cells, which stably and separately overexpress six of the seven known PML isoforms (I to VI) from a retroviral vector (Figure 2A ) [23] . Upon infection with HIV reporter virus, we found that the overexpression of the different isoforms reduced infectivity by approximately 1.5-to 3-fold in HFFs ( Figure 2B ), suggesting that the overexpression of PML also has a moderate inhibitory effect on HIV infections. However, also in part due to the heterogenic expression levels of the isoforms, we could not associate the antiviral effect of PML with a specific isoform.
Next, we asked whether the inhibitory effect of PML is specific for HIV-1 or whether other retroviruses are restricted by PML as well. We therefore transduced HFF shC and shPML cells with increasing amounts of different single-round reporter viruses. Infection with a simian immunodeficiency virus (SIV) expressing a luciferase reporter gene, a murine leukemia reporter virus (MLV) expressing GFP, a γ-retrovirus, a GFP reporter virus based on Mason-Pfizer monkey Since we found that the knockdown of PML enhanced HIV-GFP infection in HFFs, we next asked whether the overexpression of PML would be able to reduce infectivity in these cells. We therefore employed previously described HFF cells, which stably and separately overexpress six of the seven known PML isoforms (I to VI) from a retroviral vector ( Figure 2A ) [23] . Upon infection with HIV reporter virus, we found that the overexpression of the different isoforms reduced infectivity by approximately 1.5-to 3-fold in HFFs ( Figure 2B ), suggesting that the overexpression of PML also has a moderate inhibitory effect on HIV infections. However, also in part due to the heterogenic expression levels of the isoforms, we could not associate the antiviral effect of PML with a specific isoform.
Next, we asked whether the inhibitory effect of PML is specific for HIV-1 or whether other retroviruses are restricted by PML as well. We therefore transduced HFF shC and shPML cells with increasing amounts of different single-round reporter viruses. Infection with a simian immunodeficiency virus (SIV) expressing a luciferase reporter gene, a murine leukemia reporter virus (MLV) expressing GFP, a γ-retrovirus, a GFP reporter virus based on Mason-Pfizer monkey virus, a δ-retrovirus, showed similar results to the HIV-luciferase infection ( Figure 3 ). We found that all reporter viruses tested infected shPML cells about 2-to 4-fold more efficiently than HFF control cells, demonstrating that the antiviral effect of PML is not specific to HIV-1 but more generalized and affects a broader range of retroviruses.
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HIV infectivity is not enhanced in the absence of PML in T cells and myeloid cells. Human T cells and macrophages are bona fide target cells of HIV-1 infection in vivo. Unfortunately, we found the manipulation of endogenous PML levels by small interfering RNA in primary cells to be rather difficult and very inefficient. Thus, to determine whether PML affects infection in HIV target cell types, we analyzed HIV infectivity in T cell lines and myeloid cells in the absence or presence of PML. First, we generated PML knockdown (shPML) and control cells (shC) based on four different T cell lines, CEM, HuT78, Jurkat and MOLT4, which stably express shRNA directed against PML or control shRNA from a lentiviral vector. In Jurkat T cells, we found that overexpression of shRNA targeting PML efficiently reduced the number of nuclear ND10 structures compared to shC cells, indicating an efficient reduction of PML protein level in Jurkat shPML cells ( Figure 5A Figure 5B ). To exclude any cell type-specific limitations regarding the antiviral effect of PML in Jurkat cells, we generated three additional T cell lines stably expressing shPML or control shRNA ( Figure 5C,D) . The efficacy of the PML knockdown varied between the different cell lines. While in CEM and Hut78 T cells the knockdown of PML was only moderately effective, the PML protein level in Jurkat and Molt4 were reduced by 80% and 90%, respectively. However, upon infection we could not detect a significant difference in HIV infectivity between shC and shPML cells for any of the tested T cell lines. Together, our results suggest that PML does not affect HIV-1 infectivity in T cells-at least not in the T cell lines tested.
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Journal 2015, volume, page-page 12 during the viral life cycle, at or prior to reverse transcription. Fittingly, we also found a 3-to 4-fold increase in 2-LTR circles in shPML cells compared to control cells, suggesting elevated numbers of viral DNA molecules in the nucleus of shPML cells compared to control cells. An AZT control was included in the infections to control for contaminating input plasmid DNA. Together, these results suggest that PML already inhibits viral infectivity at or during reverse transcription and the subsequent nuclear import of viral cDNA. Although we cannot completely exclude additional, later mechanisms, the PML-mediated block to RT and nuclear import mirrors the magnitude of restriction measured in HIV-GFP infectivity assays, suggesting that this early restriction is the most relevant block in HIV reporter virus infection. PML blocks viral infectivity in murine embryonic fibroblasts. Within this study we found that the knockdown of PML enhances HIV-1 infectivity in primary human fibroblasts. Interestingly, a previous study using murine fibroblasts (MEFs) could not detect any differences in HIV infectivity between MEFs from PML KO and WT mice [19] . To determine whether PML restricts retroviral infection in murine fibroblasts as well, we transduced MEFs from PML knockout (KO) and wild-type (WT) mice with increasing amounts of VSV-G-pseudotyped HIV reporter virus expressing GFP under the control of a CMV promoter ( Figure 9A,B) . In contrast to the previous study, we found that the HIV infectivity in MEFs is enhanced by up to 10-fold in the absence of PML, which is an even stronger PML phenotype than in human fibroblasts. To confirm our finding PML blocks viral infectivity in murine embryonic fibroblasts. Within this study we found that the knockdown of PML enhances HIV-1 infectivity in primary human fibroblasts. Interestingly, a previous study using murine fibroblasts (MEFs) could not detect any differences in HIV infectivity between MEFs from PML KO and WT mice [19] . To determine whether PML restricts retroviral infection in murine fibroblasts as well, we transduced MEFs from PML knockout (KO) and wild-type (WT) mice with increasing amounts of VSV-G-pseudotyped HIV reporter virus expressing GFP under the control of a CMV promoter ( Figure 9A,B) . In contrast to the previous study, we found that the HIV infectivity in MEFs is enhanced by up to 10-fold in the absence of PML, which is an even stronger PML phenotype than in human fibroblasts. To confirm our finding that PML blocks retroviral infectivity in MEFs, we asked whether murine PML also inhibits HIV reverse transcription, similar to PML in human fibroblasts. We therefore transduced MEFs from KO or WT mice with HIV reporter virus and determined the number of viral RT products and 2-LTR circles at various time points postinfection (Figure 9C,D) . Similar to the situation in human fibroblasts, we found that the knockout of PML already enhanced the number of late RT products as well as 2-LTR circles upon infection of MEFs. We found that in MEFs late RT products also peak around 12 h postinfection and are about 10-fold more abundant in PML KO cells compared to WT cells ( Figure 9C) . Also, the number of 2-LTR circles was enhanced in these cells by approximately 10-fold compared to WT cells ( Figure 9D) . As for HFFs, we found that the absence of PML in murine fibroblasts also releases an early block to HIV infection that otherwise acts during or prior to reverse transcription of the viral genome.
Journal 2015, volume, page-page 13 that PML blocks retroviral infectivity in MEFs, we asked whether murine PML also inhibits HIV reverse transcription, similar to PML in human fibroblasts. We therefore transduced MEFs from KO or WT mice with HIV reporter virus and determined the number of viral RT products and 2-LTR circles at various time points postinfection (Figure 9C,D) . Similar to the situation in human fibroblasts, we found that the knockout of PML already enhanced the number of late RT products as well as 2-LTR circles upon infection of MEFs. We found that in MEFs late RT products also peak around 12 h postinfection and are about 10-fold more abundant in PML KO cells compared to WT cells ( Figure 9C) . Also, the number of 2-LTR circles was enhanced in these cells by approximately 10-fold compared to WT cells ( Figure 9D) . As for HFFs, we found that the absence of PML in murine fibroblasts also releases an early block to HIV infection that otherwise acts during or prior to reverse transcription of the viral genome. HIV infection induces a temporary localization of PML in the cytoplasm of HFFs. It has been shown in previous studies that HIV-1 infection triggers an early relocalization of PML bodies from the nucleus to the cytoplasm of infected HeLa cells [18] . To determine whether this relocalization could also explain the effect of PML on HIV reverse transcription in primary HFF cells, we analyzed the cellular localization of PML at various time points upon infection with VSV-G pseudotyped, HIV infection induces a temporary localization of PML in the cytoplasm of HFFs. It has been shown in previous studies that HIV-1 infection triggers an early relocalization of PML bodies from the nucleus to the cytoplasm of infected HeLa cells [18] . To determine whether this relocalization could also explain the effect of PML on HIV reverse transcription in primary HFF cells, we analyzed the cellular localization of PML at various time points upon infection with VSV-G pseudotyped, fluorescently labeled HIV particles (HIV-MAGFP) [25] . The particles contain a Matrix-EGFP fusion protein, which allowed us to monitor the PML distribution in infected cells prior to HIV gene expression by confocal microscopy. We determined the localization of PML in uninfected cells (mock) and infected cells at various time points postinfection, starting as early as 0.5 h after inoculation with reporter virus (MOI of 3) (Figure 10 ). We detected dot-like GFP signals in all infected but not in mock-treated samples, suggesting the presence of cell-bound HIV-GFP virions as early as 0.5 h postinfection. At 24 h postinfection, we found Gag-EGFP reporter gene expression in almost all cells, suggesting that the GFP reporter virus used is capable of productively infecting HFF cells. In untreated cells, PML was found to be localized almost exclusively in ND10 structures within the nucleus ( Figure 10A,B) . In infected samples, however, we found an increasing number of cells over time showing a cytoplasmic dot-like PML staining ( Figure 10B ). While the percentage of these cells was relative low at 0.5 h postinfection (20%), we found the frequency of cytoplasmic PML-containing cells to be increased at 1 h and 2 h postinfection and to peak around 4 h postinfection at approximately 50%. In line with a previous publication, we found that the relocalization of PML to the cytoplasm is only temporary [18] . At 24 h postinfection only nuclear, but almost no cytoplasmic PML was detectable in HIV-GFP-positive cells. It is unclear at the moment how this relocalization works and why it takes place in only 50% of the infected cells, but, interestingly, the relocalization of PML to the cytoplasm of infected cells early during infection correlates with the early effect of PML on HIV reverse transcription. Thus, these results might be a first step in shedding light on the unknown mechanism of PML restriction described within this study. [25] . The particles contain a Matrix-EGFP fusion protein, which allowed us to monitor the PML distribution in infected cells prior to HIV gene expression by confocal microscopy. We determined the localization of PML in uninfected cells (mock) and infected cells at various time points postinfection, starting as early as 0.5 h after inoculation with reporter virus (MOI of 3) (Figure 10 ). We detected dot-like GFP signals in all infected but not in mock-treated samples, suggesting the presence of cell-bound HIV-GFP virions as early as 0.5 h postinfection. At 24 h postinfection, we found Gag-EGFP reporter gene expression in almost all cells, suggesting that the GFP reporter virus used is capable of productively infecting HFF cells. In untreated cells, PML was found to be localized almost exclusively in ND10 structures within the nucleus (Figure 10A,B) . In infected samples, however, we found an increasing number of cells over time showing a cytoplasmic dot-like PML staining ( Figure 10B ). While the percentage of these cells was relative low at 0.5 h postinfection (20%), we found the frequency of cytoplasmic PML-containing cells to be increased at 1 h and 2 h postinfection and to peak around 4 h postinfection at approximately 50%. In line with a previous publication, we found that the relocalization of PML to the cytoplasm is only temporary [18] . At 24 h postinfection only nuclear, but almost no cytoplasmic PML was detectable in HIV-GFP-positive cells. It is unclear at the moment how this relocalization works and why it takes place in only 50% of the infected cells, but, interestingly, the relocalization of PML to the cytoplasm of infected cells early during infection correlates with the early effect of PML on HIV reverse transcription. Thus, these results might be a first step in shedding light on the unknown mechanism of PML restriction described within this study. 
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Within this study, we analyzed the role of PML/TRIM19 and ND10s during retroviral replication and compared the antiviral effect of PML on retroviral reporter virus infectivity in 
Within this study, we analyzed the role of PML/TRIM19 and ND10s during retroviral replication and compared the antiviral effect of PML on retroviral reporter virus infectivity in various human and murine cell types. We found that the knockdown of PML in primary human fibroblasts enhanced not only HIV-1 infectivity but also the infection of the retroviruses SIV, MLV and MPMV. Thus, our results indicate a broad antiretroviral activity of PML that is not specific to HIV-1. We knocked down PML in various cell types, including human T cell lines and myeloid cell lines, but could only detect increased HIV infectivity in human and murine fibroblasts, HFF and MEF, suggesting a cell-type specific antiretroviral effect of PML. In both cell types, we found enhanced levels of reverse transcription products in the absence of PML already 12 hours postinfection. We also found an early relocalization of PML to the cytoplasm during retroviral infection, suggesting a PML-mediated block to infection during the early phases of infection in the cytoplasm of infected cells.
Previous studies used the drug arsenic trioxide (As 2 O 3 ) to analyze the effect of PML on HIV infection [18] [19] [20] . As As 2 O 3 induces the degradation of PML and dissolves PML-NBs, it has been suggested that PML inhibits HIV-1 infection [18] . However, a second study did not detect any differences in HIV infection between murine WT and PML knockout cells and found that As 2 O 3 enhanced HIV-1 infectivity independently of PML [19] . These contradictory results could be due to the known pleiotropic effects of As 2 O 3 , which has been shown to bind and modulate many cellular targets in addition to PML [32, 33] . These interactions might also vary between the different cell types used in these initial studies. To determine whether arsenic treatment also leads to an enhancement of infection in HFF cells, we infected sodium arsenite (NaAsO 2 )-treated shPML and shControl HFFs with HIV reporter virus ( Figure 1E ). Although we found that NaAsO 2 treatment, which has been shown to very efficiently decrease cellular PML level [30] , enhanced HIV infectivity on shControl cells to the level of untreated shPML cells, we also found an enhancement of HIV infectivity on shPML HFFs upon incubation with NaAsO 2 . This finding suggests additional unspecific effects of arsenite treatment on HIV infectivity in HFFs. To avoid any further NaAsO 2 -related complications, we used shRNA-mediated PML knockdown cells or murine knockout fibroblasts to analyze the effect of PML on HIV infectivity. In contrast to Berthoux et al., we saw a clear enhancement (up to 10-fold) of HIV infection in KO MEFs compared to WT MEFs. The differential outcome may be explained by the use of MEFs from different mouse strains. The MEFs used in this study, were from mice with a C57BL/6 background, whereas Berthoux et al. used fibroblasts from 129/SV mice [19, 34] . Since the initial study did not provide expression levels of PML, it is possible that the difference in PML protein levels between WT and KO cells in their study is rather small, which might explain the absence of an antiviral effect.
In addition to murine fibroblasts, we detected enhanced retroviral infectivity in human fibroblasts expressing shRNA directed against PML. A caveat of using knockdown cells is that the knockdown of PML also changes the sub-nuclear architecture and dissolves ND10 structures. We cannot completely rule out that the down-regulation of PML abolishes the antiviral effect of another inhibitory factor localized in ND10s and therefore only indirectly blocks HIV. We therefore analyzed the influence of the knockdown of the most likely candidates for an ND10-mediated effect on retroviral infection, the permanently ND10-associated proteins Sp100 and Daxx. However, in contrast to PML, we did not detect enhanced viral infectivity in cells harboring shRNA directed against SP100 or Daxx, indicating that both proteins do not play a role in the PML-dependent inhibition of retroviral infection. To distinguish the role of PML from other ND10-associated proteins during restriction, we infected HFF cells overexpressing single PML isoforms with HIV reporter virus. Of note, testing the antiviral effect of PML by overexpression in otherwise susceptible cell lines is complicated by the fact that at least seven different isoforms of PML have hitherto been identified. In addition to the fact that the overexpression of exogenous proteins in primary cells like HFFs is rather difficult, it has been shown that foci formed by individually overexpressed PML isoforms differ from normal ND10 in terms of composition and Sp100 modification [35] . Thus, it is conceivable that multiple isoforms need to interact to efficiently inhibit retroviral infection. Nevertheless, our infection experiments showed that the overexpression of each of the single PML isoforms I to VI moderately reduces HIV reporter virus infectivity in HFFs by approximately 2-to 3-fold on average (Figure 2 ). However, we could not identify a specific isoform that mediates the antiretroviral effect of PML. Although we cannot completely rule out that the missing PML isoform VII accounts for the antiviral effect, the relative uniform and moderate antiviral activity of all six isoforms suggests that a common feature present in all isoforms, e.g., in the amino-terminal tripartite motif, might be important for the antiviral effect.
Recent work by Lusic et al. showed that PML plays a role in the transcriptional regulation of HIV during latency, presumably by interfering directly with the LTR promoter function [21] . In our study, we use single cycle reporter viruses to determine early antiviral effects during retroviral infection. The inhibitory effect of PML during HIV latency should therefore not influence our results. Nevertheless, to exclude an influence of PML on LTR promoter activity, we used a set of different lentiviral reporter constructs in our infectivity assays. In these constructs the reporter gene GFP is driven either by the HIV-1 LTR promoter, a CMV IE promoter, or the cellular EF1α promoter. We found that all three HIV reporter viruses based on the different reporter constructs are inhibited by PML to a similar extent. Although we cannot exclude that PML acts on all three of these very diverse promoters, our results suggest that the transcription of the reporter gene is not affected by PML in our single cycle infection assays. Therefore, our findings provide evidence that PML inhibits HIV replication at at least two different steps during the viral life cycle: first, at the level of transcription during HIV latency [21] , and, secondly, during or prior to reverse transcription of the viral RNA genome (Figures 7 and 8) . Thus, our finding that already reverse transcription of incoming virus particles is hampered by PML suggests a role for PML in the cytoplasm of the infected cell during this process. And indeed, we found that PML relocalizes from the nucleus to the cytoplasm of infected cells during the early phases of retroviral replication ( Figure 10 ). Interestingly, we also found that PML is only active against retroviruses in human or murine fibroblasts, suggesting a cell type-specific block. Although this experiment is hardly feasible at the moment due to the lack of isoform-specific antibodies, it will be very interesting in future studies to compare the expression pattern of the different PML isoforms in susceptible and non-susceptible cell types.
Conclusions
Our findings characterize the role of PML during retroviral infection in great detail and show that the PML-mediated restriction targets retroviral reverse transcription in the cytoplasm of human and murine fibroblasts. This study shows that PML contributes to the intrinsic restriction of retroviral infections in a cell type-dependent manner and therefore might provide a handle to unravel the unknown mechanism of the PML-mediated restriction of retrovirus.
